A. Hollander (Liverpool, GB)

University of Liverpool - Foundation Building Office of the Pro-Vice-Chancellors
Anthony Hollander is Pro-Vice-Chancellor for Research & Impact and Professor of Stem Cell Biology. He provides strategic leadership for the development of research policy and for ensuring impact of the University’s research programmes in Liverpool and around the world. He is also responsible for commercialisation of research; for developing partnerships with companies and other external stakeholders and for the training of postgraduate research students. Anthony’s research career has focussed on the development of stem cell therapies for treating diseases of cartilage. His spin-out company; Azellon Ltd; is developing a stem cell treatment for torn knee cartilage and he was previously part of a team that created the world’s first tissue engineered airway. He is former President of the International Cartilage Repair Society and is Chair of Utrecht University’s International Scientific and Societal Advisory Board for Life Sciences.

Presenter Of 2 Presentations

Extended Abstract (for invited Faculty only) Please select your topic

2.0.3 - Regenerate - The Holy Grail?

Presentation Topic
Please select your topic
Date
12.04.2022
Lecture Time
13:45 - 14:00
Room
Potsdam 1
Session Type
Plenary Session
Extended Abstract (for invited Faculty only) Basic Science

11.1.3 - Genome Analysis

Presentation Topic
Basic Science
Date
13.04.2022
Lecture Time
15:15 - 15:30
Room
Bellevue
Session Type
Special Session

Moderator Of 1 Session

Bellevue Special Session
Session Type
Special Session
Date
13.04.2022
Time
14:45 - 15:45
Room
Bellevue
Session Description
Worldwide experts discuss the role of the genome in cartilage degeneration, the implication of the mitochondria in osteoarthritis, and the identification of novel markers of cartilage injuries by omics.
Session Learning Objective
  1. Participants will acquire the latest knowledge on the implication of novel cartilage disease processes and markers using genome, omics, and system biology analyses.
CME Evaluation (becomes available 5 minutes after the end of the session)